1. Bhuiyan, Sharmin Siddique, Kinoshita, Shigeharu, Wongwarangkana, Chaninya, Asakawa, Shuichi, Watabe, Shugo. 2013. Evolution of the myosin heavy chain gene MYH14 and its intronic microRNA miR-499: muscle-specific miR-499 expression persists in the absence of the ancestral host gene. In BMC evolutionary biology, 13, 142. doi:10.1186/1471-2148-13-142. https://pubmed.ncbi.nlm.nih.gov/24059862/
2. Friedman, Thomas B, Belyantseva, Inna A, Frolenkov, Gregory I. . Myosins and Hearing. In Advances in experimental medicine and biology, 1239, 317-330. doi:10.1007/978-3-030-38062-5_13. https://pubmed.ncbi.nlm.nih.gov/32451864/
3. Lin, Yibin, Chen, Xiao, Lin, Linping, Zhu, Xiaofeng, Lin, Xian. 2024. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling. In Cellular & molecular biology letters, 29, 63. doi:10.1186/s11658-024-00583-9. https://pubmed.ncbi.nlm.nih.gov/38698330/
4. Holtz, Alexander M, VanCoillie, Rachel, Vansickle, Elizabeth A, Bupp, Caleb, Raby, Benjamin A. 2022. Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling. In Genetics in medicine : official journal of the American College of Medical Genetics, 24, 2065-2078. doi:10.1016/j.gim.2022.07.005. https://pubmed.ncbi.nlm.nih.gov/35980381/